EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics

Giulia Brigadoi iD, Giulia Camilla Demarin, Riccardo Boracchini iD, Luca Pierantoni iD, Sara Rossin, Elisa Barbieri iD, Francesca Tirelli, Anna Cantarutti iD, Gaia Tempo, Carlo Giaquinto, Marcello Lanari, Liviana Da Dalt iD und 1 weitere

Viruses · 2024

DOI: 10.3390/v16020199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Giulia Brigadoi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department for Women's and Children's Health, University of Padua, 35128 Padua, Italy. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Virus Diseases, Viruses. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory tract infections (RTIs) are the most common infectious syndromes, primarily caused by viruses. The primary objective was to compare the illness courses between historical RTIs and recent SARS-CoV-2 infections. The study cohort consisted of RTI cases evaluated at the Pediatric Emergency Departments of Padua and Bologna, discharged or admitted with microbiologically confirmed viral RTI between 1 November 2018 and 30 April 2019 (historical period) and 1 March 2020 and 30 April 2021 (recent period). We evaluated the risk of oxygen or respiratory support, hospitalization, antibiotic therapy, and complications among different viral infections. The odds ratio (OR) and the 95% confidence intervals (CIs) were estimated through mixed-effect logistic regression models, including a random intercept on the individual and hospital. We identified 767 RTIs: 359 in the historical period compared with 408 SARS-CoV-2 infections. Infections of SARS-CoV-2 had a lower risk of being admitted (OR 0.04, 95% CI 0.03–0.07), receiving respiratory support (OR 0.19, 95% CI 0.06–0.58), needing antibiotic therapy (OR 0.35, 95% CI 0.22–0.56) and developing complications (OR 0.27, 95% CI 0.14–0.51) compared to all other viral RTIs. COVID-19 in children is clinically similar to other viral RTIs but is associated with a less severe infection course. Thus, most prevention strategies implemented for SARS-CoV-2 should still be considered during RSV and Influenza epidemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanCOVID-19Virus DiseasesVirusesRespiratory Syncytial Virus, HumanOrthomyxoviridaeRespiratory Tract InfectionsRespiratory Syncytial Virus InfectionsHumansChildSARS-CoV-2Anti-Bacterial Agents

Stichwörter der Autor:innen

COVID-19Influenza virusSARS-CoV-2childrenpediatricrespiratory syncytial virusrespiratory tract infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Pediatric Infectious Diseases, Department for Women's and Children's Health, University of Padua, 35128 Padua, Italy.
  • Laboratory of Healthcare Research & Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.
  • Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Pediatric Emergency Department, Department of Women's and Children's Health, University of Padua, 35128 Padua, Italy.
  • Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario "A Gemelli" IRCCS, 00168 Rome, Italy.

ORCID-Profile: Giulia Brigadoi, Riccardo Boracchini, Luca Pierantoni, Elisa Barbieri, Anna Cantarutti, Liviana Da Dalt, Daniele Donà

Zitieren

APA

Brigadoi, G., Demarin, G. C., Boracchini, R., Pierantoni, L., Rossin, S., Barbieri, E., Tirelli, F., Cantarutti, A., Tempo, G., Giaquinto, C., Lanari, M., Da Dalt, L., & Donà, D. (2024). Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics. Viruses. https://doi.org/10.3390/v16020199

Vancouver

Brigadoi G, Demarin GC, Boracchini R, Pierantoni L, Rossin S, Barbieri E, et al. Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics. Viruses. 2024. doi:10.3390/v16020199

BibTeX
@article{Brigadoi2024,
  author = {Brigadoi, Giulia and Demarin, Giulia Camilla and Boracchini, Riccardo and Pierantoni, Luca and Rossin, Sara and Barbieri, Elisa and Tirelli, Francesca and Cantarutti, Anna and Tempo, Gaia and Giaquinto, Carlo and Lanari, Marcello and Da Dalt, Liviana and Donà, Daniele},
  title = {Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16020199}
}
Kostenlos starten →